|
Volumn 7, Issue 7, 2001, Pages 1835-1836
|
Treating Hodgkin's disease with bispecific antibodies: Both patients and antibody are limiting
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BISPECIFIC ANTIBODY;
INTERLEUKIN 1;
INTERLEUKIN 10;
INTERLEUKIN 5;
INTERLEUKIN 6;
INTERLEUKIN 7;
INTERLEUKIN 9;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
EDITORIAL;
HODGKIN DISEASE;
HUMAN;
NATURAL KILLER CELL;
PRIORITY JOURNAL;
REED STERNBERG CELL;
STEM CELL TRANSPLANTATION;
ANTIBODIES, BISPECIFIC;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD30;
HODGKIN DISEASE;
HUMANS;
RECEPTORS, IGG;
TREATMENT OUTCOME;
|
EID: 0034772874
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (1)
|
References (4)
|